Umair Mahmood

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Expanding the therapeutic Frontier: Liver transplantation for unresectable colorectal liver metastases.

Expanding the therapeutic Frontier: Liver transplantation for unresectable colorectal liver metastases.

Journal: Cancer treatment reviews
Published: March 07, 2026

Outcomes Following Radiotherapy for Oligoprogressive NSCLC on Immune Checkpoint Inhibitors: A Real-World, Multinational Experience.

Outcomes Following Radiotherapy for Oligoprogressive NSCLC on Immune Checkpoint Inhibitors: A Real-World, Multinational Experience.

Journal: Cancers
Published: November 28, 2025

ctDNA guided management of POLE mutant GI malignancies promotes exceptional responses and prolonged survival to immunotherapy.

ctDNA guided management of POLE mutant GI malignancies promotes exceptional responses and prolonged survival to immunotherapy.

Journal: Frontiers in immunology
Published: November 03, 2025

Bevacizumab in biliary tract cancer: a clinical catalyst in the era of chemo-immunotherapy?

Bevacizumab in biliary tract cancer: a clinical catalyst in the era of chemo-immunotherapy?

Journal: Journal of gastrointestinal oncology
Published: September 10, 2025

Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre Study.

Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre Study.

Journal: Cancers
Published: July 16, 2025

Impact of Long-Term Chemotherapy on Outcomes in Pancreatic Ductal Adenocarcinoma: A Real-World UK Multi-Centre Study.

Impact of Long-Term Chemotherapy on Outcomes in Pancreatic Ductal Adenocarcinoma: A Real-World UK Multi-Centre Study.

Journal: Cancers
Published: April 25, 2025

Is BEER the answer?-non-immunotherapeutic targeted maintenance treatment of chemotherapy-responsive advanced biliary tract cancers.

Is BEER the answer?-non-immunotherapeutic targeted maintenance treatment of chemotherapy-responsive advanced biliary tract cancers.

Journal: Translational gastroenterology and hepatology
Published: January 06, 2025

Optimizing outcomes and personalizing care with targeted agents in advanced cholangiocarcinoma.

Optimizing outcomes and personalizing care with targeted agents in advanced cholangiocarcinoma.

Journal: Cancer treatment reviews
Published: October 02, 2024

Neoadjuvant management of locally advanced pancreatic ductal adenocarcinoma - Heading towards a promising change in treatment paradigm.

Neoadjuvant management of locally advanced pancreatic ductal adenocarcinoma - Heading towards a promising change in treatment paradigm.

Journal: Cancer treatment reviews
Published: April 01, 2024

Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGFβ as key predictors.

Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGFβ as key predictors.

Journal: EBioMedicine
Published: January 09, 2024

Comprehensive Examination of Cholangiocarcinoma Patients Treated with Novel Targeted Therapies after Extended Molecular Profiling on Liquid Biopsies.

Comprehensive Examination of Cholangiocarcinoma Patients Treated with Novel Targeted Therapies after Extended Molecular Profiling on Liquid Biopsies.

Journal: Cancers
Published: December 23, 2023

Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional Signatures.

Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional Signatures.

Journal: Cancer research communications
Published: November 08, 2023
Showing 1-12 of 19

Last Updated: 09/26/2026